Cargando…
Limiting treatment plan complexity by applying a novel commercial tool
PURPOSE: A recently introduced commercial tool is tested to assess whether it is able to reduce the complexity of a treatment plan and improve deliverability without compromising overall quality. METHODS: Ten prostate and ten oropharynx plans of previously treated patients were reoptimized using the...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484888/ https://www.ncbi.nlm.nih.gov/pubmed/32436656 http://dx.doi.org/10.1002/acm2.12908 |
_version_ | 1783581065216000000 |
---|---|
author | Scaggion, Alessandro Fusella, Marco Agnello, Giancarmelo Bettinelli, Andrea Pivato, Nicola Roggio, Antonella Rossato, Marco A. Sepulcri, Matteo Paiusco, Marta |
author_facet | Scaggion, Alessandro Fusella, Marco Agnello, Giancarmelo Bettinelli, Andrea Pivato, Nicola Roggio, Antonella Rossato, Marco A. Sepulcri, Matteo Paiusco, Marta |
author_sort | Scaggion, Alessandro |
collection | PubMed |
description | PURPOSE: A recently introduced commercial tool is tested to assess whether it is able to reduce the complexity of a treatment plan and improve deliverability without compromising overall quality. METHODS: Ten prostate and ten oropharynx plans of previously treated patients were reoptimized using the aperture shape controller (ASC) tool recently introduced in Eclipse TPS (Varian Medical Systems, Palo Alto, CA). The performance of ASC was assessed in terms of the overall plan quality using a plan quality metric, the reduction in plan complexity through the analysis of 14 of the most common plan complexity metrics, and the change in plan deliverability through 3D dosimetric measurements. Similarly, plans optimized limiting the total number of delivered monitor units was assessed and compared. The two strategies were also combined to assess their potential combination. RESULTS: The plans optimized by exploiting the ASC generally show a reduced number of total Monitor Units, a more constant gantry rotation and a MLC modulation characterized by larger and less complicated shapes with leaves traveling shorter overall lengths. CONCLUSIONS: This first experience suggests that the ASC is an effective tool to reduce the unnecessary complexity of a plan. This turns into an increased plan deliverability with no loss of plan quality. |
format | Online Article Text |
id | pubmed-7484888 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74848882020-09-18 Limiting treatment plan complexity by applying a novel commercial tool Scaggion, Alessandro Fusella, Marco Agnello, Giancarmelo Bettinelli, Andrea Pivato, Nicola Roggio, Antonella Rossato, Marco A. Sepulcri, Matteo Paiusco, Marta J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: A recently introduced commercial tool is tested to assess whether it is able to reduce the complexity of a treatment plan and improve deliverability without compromising overall quality. METHODS: Ten prostate and ten oropharynx plans of previously treated patients were reoptimized using the aperture shape controller (ASC) tool recently introduced in Eclipse TPS (Varian Medical Systems, Palo Alto, CA). The performance of ASC was assessed in terms of the overall plan quality using a plan quality metric, the reduction in plan complexity through the analysis of 14 of the most common plan complexity metrics, and the change in plan deliverability through 3D dosimetric measurements. Similarly, plans optimized limiting the total number of delivered monitor units was assessed and compared. The two strategies were also combined to assess their potential combination. RESULTS: The plans optimized by exploiting the ASC generally show a reduced number of total Monitor Units, a more constant gantry rotation and a MLC modulation characterized by larger and less complicated shapes with leaves traveling shorter overall lengths. CONCLUSIONS: This first experience suggests that the ASC is an effective tool to reduce the unnecessary complexity of a plan. This turns into an increased plan deliverability with no loss of plan quality. John Wiley and Sons Inc. 2020-05-21 /pmc/articles/PMC7484888/ /pubmed/32436656 http://dx.doi.org/10.1002/acm2.12908 Text en © 2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, Inc. on behalf of American Association of Physicists in Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Scaggion, Alessandro Fusella, Marco Agnello, Giancarmelo Bettinelli, Andrea Pivato, Nicola Roggio, Antonella Rossato, Marco A. Sepulcri, Matteo Paiusco, Marta Limiting treatment plan complexity by applying a novel commercial tool |
title | Limiting treatment plan complexity by applying a novel commercial tool |
title_full | Limiting treatment plan complexity by applying a novel commercial tool |
title_fullStr | Limiting treatment plan complexity by applying a novel commercial tool |
title_full_unstemmed | Limiting treatment plan complexity by applying a novel commercial tool |
title_short | Limiting treatment plan complexity by applying a novel commercial tool |
title_sort | limiting treatment plan complexity by applying a novel commercial tool |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484888/ https://www.ncbi.nlm.nih.gov/pubmed/32436656 http://dx.doi.org/10.1002/acm2.12908 |
work_keys_str_mv | AT scaggionalessandro limitingtreatmentplancomplexitybyapplyinganovelcommercialtool AT fusellamarco limitingtreatmentplancomplexitybyapplyinganovelcommercialtool AT agnellogiancarmelo limitingtreatmentplancomplexitybyapplyinganovelcommercialtool AT bettinelliandrea limitingtreatmentplancomplexitybyapplyinganovelcommercialtool AT pivatonicola limitingtreatmentplancomplexitybyapplyinganovelcommercialtool AT roggioantonella limitingtreatmentplancomplexitybyapplyinganovelcommercialtool AT rossatomarcoa limitingtreatmentplancomplexitybyapplyinganovelcommercialtool AT sepulcrimatteo limitingtreatmentplancomplexitybyapplyinganovelcommercialtool AT paiuscomarta limitingtreatmentplancomplexitybyapplyinganovelcommercialtool |